After raising €54M, Dutch-based Vico Therapeutics secures €11.5M to help treat severe neurological diseases
Leiden-based Vico Therapeutics, a clinical-stage genetic medicines company, announced on Monday that it has secured €11.5M funding in a second closing of a Series B financing round from Seroba and Kurma Partners.